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USING AN ENCOUNTER–BASED DATABASE TO VALIDATE A DISEASE
PROGRESSION MODEL: LESSONS FOR MODELERS
Klein TM, Wielage RC, Furiak NM, Klein RW
Medical Decision Modeling, Inc, Indianapolis, IN, USA
OBJECTIVES: To determine whether results from a diabetes progression model were
consistent with electronic medical records for UK patients with suspected diabetes.
METHODS: A data driven simulation was conducted using an existing stochastic 
model of diabetes progression. The model uses UKPDS equations to calculate annual
transition probabilities to death and in ﬁ ve health dimensions (neuropathy, nephropa-
thy, retinopathy, CHD, and stroke). Although equations in multiple dimensions may
include the same factors (e.g. blood pressure, A1c), transitions in the various dimen-
sions are calculated independently. The database contained over 100 million encoun-
ter, patient or therapy records for 183,119 patients with suspected diabetes between 
1982 and 2005. Initial validation was attempted by creating a cohort of patients from 
the database for whom gender, birth year, diagnosis date, A1c, and blood pressure
were available. Any diagnosis in the ﬁ ve health dimensions, prior to the diabetes 
diagnosis, was noted to assign non-zero levels to the simulated patients’ starting state. 
After initial poor ﬁ t, more rigorous cleaning was done, the time frame was limited, 
and A1c was imputed from blood glucose values when possible. RESULTS: Although 
the ﬁ t was adequate for most events in the health dimensions, the model predicted far
more deaths than occurred in the cohort from the database. Compared to patients 
without A1c measurements in the database, those with A1c had 0.4 relative risk of 
death. The median birth year was eight years later for those with an A1c test. More-
over, the proportion of patients with an A1c was  6% through 1992, from 11% to 
26% from 1993–8, rising to 65% in 2001, and exceeding 90% the last two years. 
CONCLUSIONS: There are strong temporal interactions between year of birth or
diagnosis and A1c testing rate. Modelers should consult ISPOR task force reports on 
retrospective databases before assembling cohorts from longitudinal databases.
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AN APPLICATION OF MULTINOMIAL LOGIT PROPENSITY SCORE 
MATCHING IN ADULT ATTENTION–DEFICIT/HYPERACTIVITY
DISORDER (ADHD)
Slaton T1, Chaudhari P2, Kozma C3
1Independent Consultant, West Columbia, SC, USA, 2Thomas Jefferson University, 
Philadelphia, PA, USA, 3Independent Consultant, St. Helena Island, SC, USA
Researchers routinely restrict propensity score matching to two treatment group
models. Use of two groups could lead to erroneous results if there are other relevant 
treatment alternatives that are excluded; however, propensity matching with more than 
two groups is complicated. OBJECTIVES: The purpose of this methods presentation 
is to illustrate a multinomial propensity score matching approach that was used to
match patients receiving one of three ADHD medications. METHODS: A retrospec-
tive claims database (August 2000 through April 2006) was used to assign patients
to index-treatment groups based on presence of claims for Atomoxetine (ATX), Mixed 
Amphetamine Salts Extended-Release (MAS), or OROS Methylphenidate (MPH).
Propensity score methodology was used to match patients (1-to-1-to-1) from the three
Adult ADHD treatment cohorts. Patient characteristics from the 6-month pre-index 
period were used to predict index group membership using a multinomial logit model.
The model examined 20 categorical and 18 continuous explanatory variables. Three 
post-match groups were formed using exact matching and Mahalanobis-metric match-
ing within calipers deﬁ ned by the propensity score. Match quality was assessed using 
ANOVA with pair-wise tests and by plotting logits to visually inspect overlap among
propensity scores. RESULTS: Before matching, there were signiﬁ cant differences 
among index groups (ATX n  5,578; MAS n  8,034; MPH n  5,333) for nearly
all variables. Only Region (west), Visit type (ER, neurologist), and Pre-index costs 
(ER, ofﬁ ce, outpatient, and home health) were statistically similar. After matching, the 
groups (n  3,161/group), there were no signiﬁ cant differences on any of the 38 vari-
ables and there was substantial group overlap. CONCLUSIONS: By extending the
typical two-group propensity scoring to three groups, treatment groups were formed 
with balanced baseline distributions of patient characteristics and expectation of 
receiving each index treatments. This presentation provides an approach that may be 
used by researchers that want to match patients from more than 2 groups.
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RELEVANCE OF CONFERENCE ABSTRACTS AND HAND–SEARCHING
IN SYSTEMATIC REVIEWS
Karia R, Zwaferink H, Malik MU
Heron Evidence Development Ltd, Luton, UK
Results reported only in the form of conference abstracts are often included in clinical
systematic reviews. Some literature sources such as Cochrane Central include confer-
ence abstracts as part of their database, while hand-searching of relevant conferences 
may be partaken as part of the review process. OBJECTIVES: The objective of this
research was to quantify the contribution of conference abstracts to high-quality clini-
cal systematic reviews, and investigate the use of hand-searching in addition to data-
base searching for the identiﬁ cation of relevant abstracts. METHODS: Reviews were
included if they examined clinical outcomes of a pharmaceutical intervention. All
suitable reviews in Issues 3 and 4, 2008, of the Cochrane Database of Systematic 
Reviews were used. In addition, we searched the British Medical Journal between 2000 
and 2008 for suitable systematic reviews by using the search term “systematic review” 
in the title; the ﬁ rst 20 which fulﬁ lled the study criteria were included. Further, we 
examined three large clinical systematic reviews produced in-house between 2007 and 
2008. RESULTS: Thirty-seven systematic reviews were examined from the Cochrane
Database. A total of 26 reviews included no conference abstracts. Of 567 included
studies in all reviews, 25 (4%) were reported as conference abstracts only. Among the
six reviews in oncology, 10% (17/173) of the included studies were conference 
abstracts. Twenty out of 370 studies across 20 systematic reviews published in the 
BMJ were conference abstracts only; among the 10 reviews including hand-searching 
of conference proceedings, this was 7%, compared to 4% for those not. Of the 664 
studies found in in-house reviews, 79 studies were only reported in conference 
abstracts (12%), of which 44 were found only through hand-searching. CONCLU-
SIONS: Conference abstracts form a small proportion of included studies in high-
quality clinical systematic reviews. Hand-searching of conference proceedings makes 
a modest contribution to the number of included studies.
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IMPACT OF IGNORING CORRELATION BETWEEN INPUT PARAMETERS
ON VARIANCE OF COST–UTILITY RATIOS
Kan HJ, Mukherjee J
Bristol-Myers Squibb, Wallingford, CT, USA
Probabilistic sensitivity analysis in a cost-utility (CU) study often makes draws from 
distributions of model input parameters assuming independence. It was pointed out 
(O’Brien et al. 1994) that correlation between cost and effectiveness measures affects
variance of cost-effectiveness ratios. OBJECTIVES: This research shows variance of 
CU ratio may similarly be under or overestimated with potential correlation ignored. 
METHODS: The delta method was used to approximate variance of CU ratio. CU
ratio was calculated as g(Et, Ec, St, Sc)  {[EtCeStCs(1-Et-St)Cd]-[EcCeScCs(1-
Ec-Sc)Cd]treatment cost} / {[EtQeStQs(1-Et-St)Qd]-[EcQeScQs(1-Ec-Sc)Qd]}, 
with Et (Ec) being percentage of treatment (control) patients reaching efﬁ cacy end
points, St (Sc) percentage of treatment (control) patients having safety events, Ce, Cs 
and Cd costs of patients having efﬁ cacy, safety event and neither of them, Qe, Qs and
Qd quality adjusted life years for patients having efﬁ cacy, safety event and neither of 
them. Only Et, Ec, St and Sc were treated as random variables. A second-order Taylor 
series expansion of g was carried out about means of Et, Ec, St and Sc, collectively
denoted as M (it is noteworthy that a Bayesian interpretation is necessary and natural 
here when parameters are treated as random variables), resulting in (after some
algebra) variance(g) y (SEt2   SEc2)(tg(M)/tEt)2   (SSt2   SSc2)(tg(M)/tSt)2  2(SEtSt  
SEcSc)(tg(M)/tEt)(tg(M)/tSt), with S.2 denoting variance and S.. covariance. RESULTS:
Correlation between efﬁ cacy and safety parameters, if of the same sign as (tg(M)/
tEt)(tg(M)/tSt), increases variance of CU ratio, and vice versa. It can be shown that
under certain conditions, (tg(M)/tEt)(tg(M)/tSt) is positive, and thus with positive cor-
relation between efﬁ cacy and safety (meaning better efﬁ cacy associated with worse 
safety), variance of CU ratio would be underestimated if zero correlation is assumed.
CONCLUSIONS: In CU analysis, especially those based on trial data, correlation
between estimated parameters can impact uncertainty estimates around CU ratios.
PMC34
TOO MUCH ADO ABOUT INSTRUMENTAL VARIABLE APPROACH: 
IS THE CURE WORSE THAN THE DISEASE?
Baser O
University of Michigan and STATinMED Research, Ann Arbor, MI, USA
OBJECTIVES: To review the efﬁ cacy of instrumental variable models in addressing a
variety of assumption violations to ensure standard ordinary least squares estimates
are consistent. Instrumental variable models gained popularity in outcomes research 
because of their ability to consistently estimate the average causal effects even in the 
presence of unmeasured confounding. However, in order for this consistent estimation
to be achieved several conditions must hold. In this paper, we provide an overview of 
the instrumental variable approach, examine possible tests to check the prerequisite
conditions, and illustrate how weak instruments may produce inconsistent and inefﬁ -
cient results. METHODS: We use two instrumental variables and apply Shea’s partial
R-square method, the Anderson canonical correlation, and Cragg-Donald tests to 
check for weak instruments. Hall-Pexie tests are applied to see if any of these instru-
ments are redundant in the analysis. RESULTS: Total 15,956 asthma patients from a
private payer data set were examined in this study. We used controller-reliever copay
ratio and physician/practice prescribing patterns as an instrument. We demonstrated
that the former was a weak and redundant instrument producing inconsistent and
inefﬁ cient estimates of the effect of treatment. The results were worse than the results 
from standard regression analysis. CONCLUSIONS: Despite the obvious beneﬁ t of 
instrumental variable models, the method should not be used blindly. Several strong 
conditions are required for these models to work, and each of them should be tested. 
Otherwise, the results will be statistically worse than the results achieved by simply
using standard ordinary least squares.
